Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,151 | 656 | 98.8% |
| Education | $88.41 | 6 | 0.7% |
| Gift | $74.46 | 4 | 0.6% |
| Unspecified | $0 | 4 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $4,698 | 213 | $0 (2024) |
| Janssen Biotech, Inc. | $1,679 | 117 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,151 | 64 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $688.27 | 39 | $0 (2024) |
| Celgene Corporation | $403.05 | 24 | $0 (2024) |
| PFIZER INC. | $389.66 | 21 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $381.37 | 14 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $371.33 | 3 | $0 (2024) |
| Synergy Pharmaceuticals Inc | $291.43 | 16 | $0 (2018) |
| Gilead Sciences, Inc. | $282.84 | 9 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,438 | 128 | ABBVIE INC. ($749.44) |
| 2023 | $2,879 | 140 | AbbVie Inc. ($973.43) |
| 2022 | $1,998 | 97 | ABBVIE INC. ($794.37) |
| 2021 | $707.64 | 30 | AbbVie Inc. ($219.86) |
| 2020 | $375.32 | 21 | AbbVie Inc. ($123.10) |
| 2019 | $1,629 | 75 | AbbVie, Inc. ($560.40) |
| 2018 | $1,729 | 92 | AbbVie, Inc. ($811.80) |
| 2017 | $1,557 | 87 | AbbVie, Inc. ($465.58) |
All Payment Transactions
670 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: Gastroenterology | ||||||
| 12/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $30.49 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $5.03 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: GI | ||||||
| 12/04/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/14/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $1.73 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $2.03 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Immunology | ||||||
| 11/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.03 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $2.04 | General |
| Category: Immunology | ||||||
| 11/04/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $9.19 | General |
| Category: GI | ||||||
| 11/01/2024 | Sandoz Inc. | HYRIMOZ (Biological) | Food and Beverage | In-kind items and services | $27.72 | General |
| Category: Immunology | ||||||
| 10/29/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $22.85 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: Gastroenterology | ||||||
| 10/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $1.50 | General |
| Category: IMMUNOLOGY | ||||||
| 10/20/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: IMMUNOLOGY | ||||||
| 10/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $27.62 | General |
| Category: Immunology | ||||||
| 10/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $3.64 | General |
| Category: Immunology | ||||||
| 10/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: Immunology | ||||||
| 10/05/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 899 | 7,603 | $1.1M | $218,124 |
| 2022 | 15 | 977 | 7,125 | $1.0M | $201,634 |
| 2021 | 18 | 1,140 | 10,922 | $1.1M | $280,082 |
| 2020 | 17 | 902 | 10,683 | $929,097 | $249,416 |
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J3380 | Injection, vedolizumab, 1 mg | Office | 2023 | 11 | 6,607 | $330,000 | $113,167 | 34.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 140 | 141 | $200,925 | $29,143 | 14.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 243 | 245 | $304,995 | $25,690 | 8.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 162 | 229 | $34,350 | $13,848 | 40.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 84 | 98 | $20,776 | $8,512 | 41.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 99 | 104 | $96,175 | $6,998 | 7.3% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 36 | 36 | $50,968 | $6,497 | 12.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 44 | 44 | $14,432 | $5,002 | 34.7% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 43 | 43 | $31,175 | $4,817 | 15.5% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 11 | 11 | $13,090 | $1,611 | 12.3% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 13 | 31 | $4,526 | $1,448 | 32.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 13 | 14 | $4,200 | $1,393 | 33.2% |
| J3380 | Injection, vedolizumab, 1 mg | Office | 2022 | 13 | 6,010 | $282,000 | $99,655 | 35.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 116 | 118 | $169,262 | $23,133 | 13.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 210 | 210 | $261,172 | $20,703 | 7.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 183 | 252 | $38,043 | $14,380 | 37.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 107 | 125 | $26,695 | $11,177 | 41.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 112 | 118 | $105,543 | $8,607 | 8.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 52 | 52 | $17,056 | $5,754 | 33.7% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 22 | 22 | $31,277 | $3,991 | 12.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 37 | 38 | $11,772 | $3,824 | 32.5% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2022 | 30 | 31 | $23,154 | $3,314 | 14.3% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 31 | 60 | $8,840 | $1,817 | 20.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 23 | 23 | $5,650 | $1,503 | 26.6% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 14 | 34 | $5,984 | $1,470 | 24.6% |
About Dr. Robert Clark, MD
Dr. Robert Clark, MD is a Internal Medicine healthcare provider based in Bloomington, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2008. The National Provider Identifier (NPI) number assigned to this provider is 1033372727.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Clark, MD has received a total of $13,314 in payments from pharmaceutical and medical device companies, with $2,438 received in 2024. These payments were reported across 670 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($13,151).
As a Medicare-enrolled provider, Clark has provided services to 3,918 Medicare beneficiaries, totaling 36,333 services with total Medicare billing of $949,256. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Gastroenterology, Gastroenterology
- Location Bloomington, IL
- Active Since 07/03/2008
- Last Updated 06/28/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1033372727
Products in Payments
- RINVOQ (Biological) $1,273
- Humira (Biological) $1,251
- STELARA (Biological) $1,098
- SKYRIZI (Biological) $758.35
- XIFAXAN (Drug) $741.99
- ZEPOSIA (Drug) $615.76
- ENTYVIO (Biological) $582.69
- DUPIXENT (Biological) $567.53
- Entyvio (Biological) $538.13
- REMICADE (Biological) $438.10
- LINZESS (Drug) $367.41
- HUMIRA (Biological) $359.63
- XELJANZ (Drug) $347.69
- TREMFYA (Drug) $300.77
- Trulance (Drug) $291.43
- Cimzia (Drug) $265.86
- Epclusa (Drug) $204.53
- ZENPEP (Drug) $170.08
- VIBERZI (Drug) $163.88
- IBSRELA (Drug) $143.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Bloomington
Desiree Ortiz-Cruz, Md, MD
Internal Medicine — Payments: $191,757
Dr. Joan Crawford, Do, DO
Internal Medicine — Payments: $186,460
Dr. Omar Khokhar, Md, MD
Internal Medicine — Payments: $133,324
Dr. William Schmalz, Md, MD
Internal Medicine — Payments: $131,004
Avani Desai, Md Mbbs, MD MBBS
Internal Medicine — Payments: $29,268
Dr. Sven Klauss, M.d, M.D
Internal Medicine — Payments: $19,876